1999
DOI: 10.1016/s0165-5728(99)00084-3
|View full text |Cite
|
Sign up to set email alerts
|

Adhesion molecule expression and regulation on cells of the central nervous system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

7
182
1
6

Year Published

2001
2001
2016
2016

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 271 publications
(196 citation statements)
references
References 107 publications
7
182
1
6
Order By: Relevance
“…7d). Other adhesion molecule receptors that we tested, such as leukotactic factor activity-1, intercellular adhesion molecule, and vascular cell adhesion molecule (Lee and Benveniste, 1999), did not show any dopamine-related changes in Treg (data not shown).…”
Section: Dopamine Alters the Adhesive And Migratory Properties Of Tregmentioning
confidence: 86%
“…7d). Other adhesion molecule receptors that we tested, such as leukotactic factor activity-1, intercellular adhesion molecule, and vascular cell adhesion molecule (Lee and Benveniste, 1999), did not show any dopamine-related changes in Treg (data not shown).…”
Section: Dopamine Alters the Adhesive And Migratory Properties Of Tregmentioning
confidence: 86%
“…However, in the absence of the ability to spontaneously harness Teff (as in wild-type C57BL͞6J mice) or in immune-deficient mice, Treg can induce the microglia to adopt a favorable phenotype. The effects of Treg and Teff on microglia are evidently expressed via different and even mutually antagonistic cytokines and therefore probably via different intracellular pathways (47,48). Nevertheless, both T cell populations are capable of ensuring that the innate response represented by the microglia will be properly regulated.…”
Section: Discussionmentioning
confidence: 99%
“…Endothelial cells upregulate the expression of both these molecules in response to TNF, IL-1 and LPS [33][34][35][36]40]. In addition, VCAM-1 and fractalkine are expressed in many of the same inflammatory diseases, including murine models of cardiac allograft rejection [19,41,42], crescentric nephritis [20,43] and experimental autoimmune encephalomyelitis [21,22,44]. Blockade of fractalkine-CX 3 CR1 interactions is beneficial in a murine model of crescentric glomerulonephritis [20].…”
Section: Discussionmentioning
confidence: 99%